Article 1: 3D Lung Models and India’s Fight Against Tuberculosis
Why in News: Researchers at IISc Bengaluru have developed a 3D lung tissue model that significantly improves testing of tuberculosis (TB) drugs, offering new hope in India’s TB elimination efforts.
Key Details
- IISc researchers created a 3D collagen-based lung model that closely mimics the human lung microenvironment.
- The model shows realistic TB features such as fat-laden immune cells and bacterial clusters.
- It successfully demonstrated the efficacy of Pyrazinamide, which earlier lab models failed to replicate.
- The research is funded by India Alliance (DBT–Wellcome Trust partnership).
Tuberculosis Burden in India
- High Disease Load: India accounts for one of the world’s largest TB burdens, with around 2.5–3 million cases annually, making TB a major public health challenge.
- Drug-Resistant TB Hotspot: India is among the top contributors to MDR-TB and Rifampicin-Resistant TB (RR-TB) globally, complicating treatment and increasing mortality risks.
- Economic and Social Impact: TB disproportionately affects the working-age population, leading to loss of productivity, healthcare costs, and social stigma.
- National Commitment: Under the National TB Elimination Programme (NTEP), India aims to eliminate TB by 2025, ahead of the global SDG target of 2030.
Limitations of Existing TB Drug Testing Models
- Planktonic Bacterial Cultures: Basic drug testing on free-floating TB bacteria fails to capture host–pathogen interactions present in human lungs.
- 2D Cell Culture Models: Flat mammalian cell cultures lack the structural and mechanical complexity of lung tissue, leading to poor prediction of drug efficacy.
- Animal Models: While useful, animal models such as mice often show limited translation to human responses, raising ethical and scientific concerns.
- Regulatory Shift: New frameworks like the FDA Modernization Act 3.0 (USA) and New Drugs and Clinical Trials Rules (India) encourage alternatives to animal testing.
Significance of the 3D Lung Model Developed by IISc
- Realistic Lung Microenvironment: The soft collagen hydrogel mimics lung tissue structure, providing biochemical and mechanical cues similar to human lungs.
- Improved Disease Representation: The model replicates fat-filled immune cells and bacterial clusters, key pathological features of TB seen in patients.
- Accurate Drug Response: It successfully demonstrated the action of Pyrazinamide, a first-line TB drug whose efficacy is poorly reflected in older models.
- Scalable and Modular Design: The system is easy to reproduce, scalable, and suitable for long-term infection studies, making it useful for drug screening.
Relevance for Drug-Resistant TB Research
- Testing Against MDR/XDR-TB: The model can potentially be used with drug-resistant clinical TB isolates to identify effective new drug combinations.
- Understanding Granulomas: Researchers aim to mimic TB granulomas, dense immune cell structures that restrict drug penetration and cause treatment failure.
- Faster Drug Development: Reliable pre-clinical testing can reduce time, cost, and failure rates before human clinical trials.
- Strengthening Indigenous Research: The innovation reflects India’s growing capacity in biomedical research and translational science.
Linkages with Policy, Innovation, and SDGs
- Health and SDGs: Supports SDG 3 (Good Health and Well-being) by accelerating innovation against infectious diseases.
- Atmanirbhar Bharat in Science: Demonstrates indigenous R&D capability aligned with self-reliance in health technologies.
- Public–Private and Global Collaboration: Funding through DBT–Wellcome Trust partnership highlights the role of international scientific cooperation.
- Ethical Research Practices: Reduced dependence on animal testing aligns with ethical and sustainable research norms.
Conclusion
The IISc-developed 3D lung model marks a significant leap in TB research by bridging the gap between laboratory testing and real human disease conditions. By enabling accurate drug efficacy testing, including for drug-resistant TB, it strengthens India’s fight against one of its most persistent public health challenges. Integrating such innovations with national TB programmes and regulatory reforms can accelerate progress toward TB elimination and reinforce India’s leadership in affordable health innovation.
EXPECTED QUESTION FOR UPSC CSE
Prelims MCQ
Q. The recently developed 3D lung model by IISc Bengaluru is significant because it:
- Accurately mimics the human lung microenvironment for TB research
- Helps test the efficacy of TB drugs like Pyrazinamide
- Can potentially aid research on drug-resistant TB
- Aligns with global regulatory shifts towards non-animal testing
Select the correct answer using the code below:
(a) 1 and 2 only
(b) 1, 2 and 3 only
(c) 2 and 4 only
(d) 1, 2, 3 and 4
Answer: (d)